GlassScriptPhysician profile
James R Rappaport
NPI 1619953791
$11,987.65
in general payments reported to CMS, 2019-2025
16 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,867 · 2020: $6.27 · 2021: $83.63 · 2022: $81.95 · 2023: $166 · 2024: $4,407 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,903 · Food and Beverage: $895 · Entertainment: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,902.83 |
| Food and Beverage | $894.68 |
| Entertainment | $151.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $6,739.33 | 2019 | |
| Nexxt Spine LLC | $3,053.90 | 2024 | Nexxt Spine Product Offerings, Nexxt Matrixx Cervical Systems |
| Highridge Medical LLC | $1,241.82 | 2024 | Mobi-C Plug & Fit US |
| Cerapedics INC. | $228.41 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $160.49 | 2023-2025 | Unid_pass, Kyphon Express II Kyphopak Tray |
| Ossdsign USA Incorporated | $118.87 | 2025 | Ossdsign Catalyst |
| Nevro Corp. | $92.18 | 2019 | |
| Surgalign Spine Technologies, INC. | $83.63 | 2021 | |
| Baxter Healthcare | $81.95 | 2022 | |
| Next Science LLC | $38.50 | 2024 | Surgx, Blastx, Xperience |
| Wenzel Spine, INC. | $35.50 | 2019 | |
| Si-Bone, INC. | $33.75 | 2020-2025 | |
| Bioventus LLC | $33.11 | 2024 | Gelsyn-3 |
| Zimvie INC. | $26.77 | 2023 | |
| Biocomposites INC | $19.44 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rappaport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.